Oral Oncology
Volume 45, Issue 1 , Pages e1-e8 , January 2009

The involvement of promoter methylation and DNA methyltransferase-1 in the regulation of EpCAM expression in oral squamous cell carcinoma

  • Shine-Gwo Shiah

      Affiliations

    • Institute of Cancer Research, National Health Research Institutes, Miaoli 350, Taiwan
    • ,
  • Long-Chang Chang

      Affiliations

    • Department of Oral Diagnosis and Pathology, Tri-Service General Hospital, No. 325, Section 2, Cheng-Kung Road, Neihu 114, Taipei, Taiwan
    • ,
  • Kang-Yu Tai

      Affiliations

    • Institute of Cancer Research, National Health Research Institutes, Miaoli 350, Taiwan
    • ,
  • Ghien-Hsing Lee

      Affiliations

    • Department of Internal Medicine, Tri-Service General Hospital, No. 325, Section 2, Cheng-Kung Road, Neihu 114, Taipei, Taiwan
    • ,
  • Cheng-Wen Wu

      Affiliations

    • Institute of Cancer Research, National Health Research Institutes, Miaoli 350, Taiwan
    • ,
  • Yi-Shing Shieh

      Affiliations

    • Department of Oral Diagnosis and Pathology, Tri-Service General Hospital, No. 325, Section 2, Cheng-Kung Road, Neihu 114, Taipei, Taiwan
    • School of Dentistry, National Defense Medical Center, P.O. Box 90048-503, Taipei, Taiwan
    • Corresponding Author InformationCorresponding author. Address: School of Dentistry, National Defense Medical Center, P.O. Box 90048-503, Taipei, Taiwan. Tel.: +886 2 87923148; fax: +886 2 87919276.

Received 8 December 2007 ,Revised 5 March 2008 ,Accepted 6 March 2008.

References 

  1. Armstrong A, Eck SL. EpCAM: a new therapeutic target for an old cancer antigen. Cancer Biol Ther. 2003;2(4):320–326
  2. Winter MJ, et al. The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. Am J Pathol. 2003;163:2139–2148
  3. Went PT, et al. Frequent EpCam protein expression in human carcinomas. Hum Pathol. 2004;35:122–128
  4. Brunner A, et al. EpCAM is predominantly expressed in high grade and advanced stage urothelial carcinomas of the bladder. J Clin Pathol. 2008;61:307–310
  5. Seligson DB, et al. Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma. Clin Cancer Res. 2004;10:2659–2669
  6. Tai KY, et al. DNA methylation and histone modification regulate silencing of epithelial cell adhesion molecule for tumor invasion and progression. Oncogene. 2007;26:3989–3997
  7. Songun I, et al. Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer. Br J Cancer. 2005;92:1767–1772
  8. High AS, Robinson PA, Klein CE. Increased expression of a 38kd cell-surface glycoprotein MH99 (KS 1/4) in oral mucosal dysplasias. J Oral Pathol Med. 1996;25:10–13
  9. Laimer K, et al. EpCAM expression in squamous cell carcinoma of the oral cavity: Frequency and relationship to clinicopathologic features. Oral Oncol. 2007;44:72–77
  10. Yanamoto S, et al. Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy. Oral Oncol. 2007;43:869–877
  11. Rao CG, et al. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. Int J Oncol. 2005;27:49–57
  12. Jojovic M, et al. Epithelial glycoprotein-2 expression is subject to regulatory processes in epithelial-mesenchymal transitions during metastases: an investigation of human cancers transplanted into severe combined immunodeficient mice. Histochem J. 1998;30:723–729
  13. Esteller M, Herman JG. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol. 2002;196:1–7
  14. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3:415–428
  15. Turek-Plewa J, Jagodzinski PP. The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol Biol Lett. 2005;10:631–647
  16. Gaudet F, et al. Induction of tumors in mice by genomic hypomethylation. Science. 2003;300:489–492
  17. Robertson KD. DNA methylation, methyltransferases, and cancer. Oncogene. 2001;20:3139–3155
  18. Kautiainen TL, Jones PA. DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture. J Biol Chem. 1986;261:1594–1598
  19. Saito Y, et al. Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int J Cancer. 2003;105:527–532
  20. Hammons GJ, et al. Increased expression of hepatic DNA methyltransferase in smokers. Cell Biol Toxicol. 1999;15:389–394
  21. Sun L, et al. Increased DNA methyltransferase expression is associated with an early stage of human hepatocarcinogenesis. Jpn J Cancer Res. 1997;88:1165–1170
  22. De Marzo AM, et al. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. Cancer Res. 1999;59:3855–3860
  23. Liu SY, et al. Clinicopathologic significance of tumor cell-lined vessel and microenvironment in oral squamous cell carcinoma. Oral Oncol. 2007;44:277–285
  24. Shieh YS, et al. DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma. Cancer. 2005;104:1013–1021
  25. Litvinov SV, et al. Ep-CAM: a human epithelial antigen is a homophilic cell–cell adhesion molecule. J Cell Biol. 1994;125:437–446
  26. Takes RP, et al. Markers for assessment of nodal metastasis in laryngeal carcinoma. Arch Otolaryngol Head Neck Surg. 1997;123:412–419
  27. Spizzo G, Gastl G, Obrist P, Fong D, Haun M, Grunewald K, et al. Methylation status of the Ep-CAM promoter region in human breast cancer cell lines and breast cancer tissue. Cancer Lett. 2007;246:253–261
  28. Bestor T, et al. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J Mol Biol. 1988;203:971–983
  29. Etoh T, et al. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am J Pathol. 2004;164:689–699
  30. Eads CA, et al. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res. 1999;59:2302–2306
  31. Saito Y, et al. Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. Hepatology. 2001;33:561–568
  32. Sato M, et al. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines. Oncogene. 2002;21:4822–4829
  33. Doki Y, et al. Correlation between E-cadherin expression and invasiveness in vitro in a human esophageal cancer cell line. Cancer Res. 1993;53:3421–3426
  34. Hermann A, Gowher H, Jeltsch A. Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol Life Sci. 2004;61:2571–2587
  35. Ji W, et al. DNA demethylation and pericentromeric rearrangements of chromosome 1. Mutat Res. 1997;379:33–41
  36. Chuang LS. Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. Science. 1997;277:1996–2000
  37. Fuks F, et al. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat Genet. 2000;24:88–91
  38. Baylin SB, et al. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet. 2001;10:687–692

PII: S1368-8375(08)00086-9

doi: 10.1016/j.oraloncology.2008.03.003

Oral Oncology
Volume 45, Issue 1 , Pages e1-e8 , January 2009

Article Tools

* Image Usage & Resolution